STRATEGY IN DRUG DESIGN

被引：0
|
作者：
HANSCH, C
机构：
来源：
CANCER CHEMOTHERAPY REPORTS PART 1 | 1972年 / 56卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：433 / &
相关论文
共 50 条
  • [1] Drug design strategy aims for disorder
    不详
    CHEMICAL & ENGINEERING NEWS, 2008, 86 (09) : 31 - 31
  • [2] The Application of Deuteration Strategy in Drug Design
    Chen, Yuzhu
    Du, Yunfei
    CHEMMEDCHEM, 2025,
  • [3] Polyvalency: A promising strategy for drug design
    Vance, David
    Shah, Mrinal
    Joshi, Amit
    Kane, Ravi S.
    BIOTECHNOLOGY AND BIOENGINEERING, 2008, 101 (03) : 429 - 434
  • [4] STRATEGY AND TACTICS IN MOLECULAR MODELING IN DRUG DESIGN
    MUELLER, K
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1989, 7 (02): : 93 - 93
  • [5] STRATEGY IN DRUG DESIGN - CLUSTER-ANALYSIS
    UNGER, SH
    HANSCH, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1974, : 4 - 4
  • [6] Flexibility as a Strategy in Nucleoside Antiviral Drug Design
    Peters, H. L.
    Ku, T. C.
    Seley-Radtke, K. L.
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (34) : 3910 - 3921
  • [7] Benzothiazoles: How Relevant in Cancer Drug Design Strategy?
    Singh, Meenakshi
    Singh, Sushil K.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2014, 14 (01) : 127 - 146
  • [8] Drug design based on the carbon/silicon switch strategy
    Tacke, Reinhold
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [9] Drug design based on the carbon/silicon switch strategy
    Lazareva, N. F.
    Lazarev, I. M.
    RUSSIAN CHEMICAL BULLETIN, 2015, 64 (06) : 1221 - 1232
  • [10] Drug design based on the carbon/silicon switch strategy
    N. F. Lazareva
    I. M. Lazarev
    Russian Chemical Bulletin, 2015, 64 : 1221 - 1232
12345